Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Stretch Mark Cream

Follow-Up Study Further Reinforces The Long-Term Benefits Of Tight Glucose Control In Early Treatment Of Diabetes
A study published in today"s issue of the Archives of Internal Medicine provides further reinforcement that tight control of blood glucose as soon as possible after a diagnosis of type 1 diabetes yields long-term benefits with regard to lowering the rates of eye, kidney and heart complications associated with diabetes. These findings stem from the landmark Diabetes Control and Complications Trial (DCCT) and its follow-up study, the Epidemiology of Diabetes Interventions and Complications (EDIC), both funded by the National Institutes of Health.
generic viagra online
Some Strategic Limitation On Individual Knowledge Could Improve The Performance Of A Large And Complex Group, Ant Study Suggests
In a study released online on July 22 in the journal Proceedings of the Royal Society: Biological Sciences, researchers at Arizona State University and Princeton University show that ants can accomplish a task more rationally than our - multimodal, egg-headed, tool-using, bipedal, opposing-thumbed - selves. Drugshop to buy zoloft online and other pills.
News of the day
Siemens Enterprise Communications To Provide Multi-million Pound Secure LAN For Barts And The London NHS Trust Hospitals
Siemens Enterprise Communications has won a four year multi-million pound framework contract to provide Barts and The London NHS Trust with an integrated Enterasys fixed and wireless LAN and security infrastructure. The first phase in a three stage communications programme, the new infrastructure - due for completion in 2010 - will provide a single network able to handle all optical images, video streaming and traffic from multiple wireless devices and PCs for 300 beds at Barts hospital.
Sexual Health

KCI Announces FDA Clearance Of ABThera™ Open Abdomen Dressing

Kinetic Concepts, Inc. (NYSE: KCI) announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its ABThera™ Open Abdomen Dressing. Earlier this year, the FDA cleared the ABThera™ Open Abdomen Negative Pressure Therapy Unit. Together, the ABThera™ Open Abdomen Negative Pressure Therapy System will be indicated for temporary bridging of abdominal wall openings where primary closure is not possible or repeat abdominal entries are necessary. The intended use of the system is for open abdominal wounds, with exposed viscera, including but not limited to abdominal compartment syndrome. This unique, proprietary system is designed to improve therapy in the management of the complex open abdomen by actively removing fluids and infectious material, and by reducing interstitial edema, thus assisting in primary fascial closure of abdominal wall. The ABThera™ Open Abdomen Negative Pressure Therapy System expands the offerings of KCI"s negative pressure technology platform into the surgical and trauma operating theaters. "We are pleased to receive clearance for this important therapy," said Catherine M. Burzik, KCI"s President and CEO. "At KCI, we continue to leverage our strengths and core technology competencies to provide high impact therapies and address clinical unmet needs. Expansion and growth in the surgical arena is a strategic goal for the company and we look forward to launching the ABThera™ Open Abdomen Negative Pressure Therapy System this summer." Kinetic Concepts, Inc


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009